Pharmaceutical R&D productivity: The role of alliances

Journal of Commercial Biotechnology

Volumn 20, Issue 2, 2014, Pages 11-20

  Kruse, Sarah ^a   Slomiany, Mark ^a,b,c,d   Bitar, Rema ^a,e   Jeffers, Sarah ^a,f,g   Hassan, Mahmud ^a,e,h,i  

^a RUTGERS BUSINESS SCHOOL   (United States)

^b WASHINGTON AND LEE UNIVERSITY   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d Applied Glycan LLC   (United States)

^e Blanche and Irwin Lerner Center   (United States)

^f Lerner Center   (United States)

^g MERCK RESEARCH LABORATORIES   (United States)

^h Department of Finance and Economics ^*  (United States)

ⁱ Pharmaceutical Management Program   (United States)

Author keywords

Alliance; Big data; CRO; Productivity; R d

Indexed keywords

CATHODE RAY OSCILLOSCOPES; INDUSTRY; PRODUCTIVITY;

ACADEMIC INSTITUTIONS; ALLIANCE; BIG DATUM; INCREASED PRODUCTIVITY; PUBLIC PRIVATE PARTNERSHIPS; RESEARCH INSTITUTIONS; ROLE OF TECHNOLOGIES; TECHNOLOGY POLICY;

RESEARCH;

ARTICLE; BIOTECHNOLOGY; CLINICAL RESEARCH; COMMERCIAL PHENOMENA; DIVERSIFYING SELECTION; DRUG INDUSTRY; GOVERNMENT; PHARMACEUTICS; PRODUCTIVITY;

EID: 84898469508     PISSN: 14628732     EISSN: 1478565X     Source Type: Journal    
DOI: 10.5912/jcb632     Document Type: Article

References (31)

1. PricewaterhouseCoopers. (2007) Pharma 2020: The vision; Which path will you take? PricewaterhouseCoopers. June; 1-52. Available from: BioValley, Basel, Switzerland. Accessed 23 March 2013.
2. Congressional Budget Office. (2006) Research and Development in the Pharmaceutical Industry. Congress of the United States, Congressional Budget Office. October.
3. Terblanche, N. (2008) New pharmaceutical product development: Barriers to overcome and opportunities to exploit. Journal Of Commercial Biotechnology [serial online]. July; 14(3): 201-212. Available from: Business Source Premier, Ipswich, MA. Accessed 9 March 2013.
4. Kola, I. and Landis, J. (2004) Can the Pharmaceutical Industry Reduce Attrition Rates? Nature Reviews Drug Discovery. August; 3: 711-715.
5. Danzon, P.M., Nicholson, S. and Pereira, N.S. (2005) "Productivity in Pharmaceutical-Biotechonology R&D: the Role of Experience and Alliances", Journal of Health Economics. March; 24(2): 317-339.
6. Hoang, H.A. and Rothaermel, F.T. (2005) "The Effect of General and Partner-Specific Alliance Experience on Joint R&D Project Performance", Academy of Management Journal 48(2): 332-345.
7. Grabowski, H. and Kyle, M. (2008) "Mergers and Alliances in Pharmaceuticals: Effects on Innovation and R&D Productivity", in Economics of Corporate Governance and Mergers, ed. Gugler, Klaus and Yurtoglu, B. Burcin, published by Edward Elgar, November.
8. Schiele, H. (2010) Early supplier integration: the dual role of purchasing in new product development. R&D Management [serial online]. March; 40(2): 138-153. Available from: Business Source Premier, Ipswich, MA. Accessed 21 February 2013.
9. David, E., Mehta, A., Norris, T., Singh, N. and Tramontin, T. (2014) New frontiers in pharma R&D investment. McKinsey & Co. Insights & Publiations. February 2010. http://www.mckinsey.com/insights/health-systems-and- services/new-frontiers-in-pharma-r-and-38d-investment Accessed 24 February 2014.
10. Booth B. (2011) Debunking Corporate Venture Capital in Biotech. Opinion. LifeSciVC.com. September. http://lifescivc.com/2011/09/debunking-corporate- venture-capital-in-biotech
11. Yang S. (2012) Pharmaceutical innovation: AstraZeneca's experience in China. Mckinsey Quarterly [serial online]. March; 1: 93-95. Available from: Business Source Premier, Ipswich, MA. Accessed 9 March 2013.
12. Areddy, J. (2012) Scientist Convicted of Stealing Merck Drugs. Wall Street Journal. June. Available from: WSJ online. Accessed 9 April 2013.
13. Aris, R. (2011) Patient and Industry Engagement. Pharmaphorum. http://www.pharmaphorum.com/articles/patient-and-industry-engagement. 28 October 2011.
14. Kielstra, P. (2012) The Patient-Led R&D Strategy. Economist Intelligence Unit. October; 1-32. Accessed 9 March 2013.
15. https://www.vrtx.com/sites/default/files/assets/pdfs/ VertexCFFCollaborationBackgrounder.pdf. Accessed 14 February 2014.
16. Madhur, S. (2008) Should Clinical Trials Be Outsourced? TIME, http://www.time.com/time/health/article/0,8599,1830334,00.html. Accessed 7 August 2008
17. Nourmohammadi, N. (2012) FierceCROs Top 5 Strategic CRO/Pharma Partnerships. Fierce CRO Web site. http://www.fiercecro.com/story/fiercecros- top-5-strategic-cropharma-partnerships/2012-06-14. 14 June 2012. Accessed 5 April 2013.
18. Miller, J. (2012) CROs and CMOS Have Cause to Celebrate. Pharmaceutical Technology Europe [serial online]. October; 24(10): 20-26. Available from: Business Source Premier, Ipswich, MA. Accessed 4 April 2013.
19. Getz, K.A. (2006) Insights from Today's CRO Renaissance. Applied Clinical Trials Web Site. http://www.appliedclinicaltrialsonline.com/ appliedclinicaltrials/ article/articleDetail.jsp?id=334568&sk=&date= &%0A%09%09%09&pageID=2. 1 June 2006. Accessed 5 April 2013.
20. Getz, K.A. (2009) Successful Outsourcing: Tracking Global CRO Usage. Applied Clinical Trials Web Site. http://www.appliedclinicaltrialsonline.com/ appliedclinicaltrials/article/articleDetail.jsp?id=619120 &sk=&date= &%0A%09%09%09&pageID=5. 17 August 2009. Accessed 5 April 2013.
21. Kaitin, K. (2011) 21st Century Bioinnovation. Pharmaceutical Technology [serial online]. June; 35(6):32. Available from: Business Source Premier, Ipswich, MA. Accessed 12 April 2013.
22. Collier, R. and McBride, R. (2012) The Insider Perspective; Academic & Pharma Partnerships: Tapping the Ivory Tower for the Next Blockbuster. FiercePharma eBook. February. Available from: FiercePharma. Accessed 8 April 2013.
23. Collier, R. and McBride, R. (2012) Pitfalls, Horror Stories, and Cautionary Tales. Academic & Pharma Partnerships: Tapping the Ivory Tower for the Next Blockbuster FiercePharma eBook. February. Available from: FiercePharma. Accessed 8 April 2013.
24. Toor, S. and McBride R. (2013) 20 Major Pharma-Academic Alliances in 2012. FierceBiotech Web Site. http://www.fiercebiotech.com/slideshows/20-major- pharma-academic-alliances-2012. Accessed 9 March 2013.
25. Richards, D. and Dalton, B. (2009) Collaboration in research protocol design: A case study exploring knowledge creation for the pharmaceutical industry and prescribing physicians. Journal Of Medical Marketing [serial online]. July; 9(3): 213-220. Available from: Business Source Premier, Ipswich, MA. Accessed 9 March 2013.
26. Blakeslee, W. (2012) Licensing, partnering, strategic alliances and university relationships. Journal Of Commercial Biotechnology [serial online]. March; 18(2): 68-71. Available from: Business Source Premier, Ipswich, MA. Accessed 9 March 2013. 27. http://www.pfizer.com/research/rd-partnering/centers- for-therapeutic-innovation. Accessed 14 February 2014
27. Schachter, B. (2012) Pfizer's Centers for Therapeutic Innovation. Nature Biotechnology. October.
28. Groves, P., Kayyali, B., Knott, D. and Van Kuiken, S. (2013) The "big data" revolution in healthcare: Accelerating value and innovation. Center for US Health System Reform, Business Technology Office. McKinsey & Company. January.
29. Hede, K. (2013) Project Data Sphere to make cancer clinical trial data publicly available. Journal of the National Cancer Institute. 21 July 2013.
30. Bhattacharjee, Y. (2012) Pharma Firms Push for Sharing Of Cancer Trial Data. Science. 338:29. October.
31. http://www.transceleratebiopharmainc.org/ Accessed 6 August 2013